Investor 1Globe Capital LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by 1Globe Capital LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-20 13G 896,712
2025-07-07 13D/A SVA / Sinovac Biotech, Ltd. 18,515,315 18,515,315
2025-07-03 13D/A SVA / Sinovac Biotech, Ltd. 18,515,315 18,515,315
2025-07-01 13D/A SVA / Sinovac Biotech, Ltd. 18,515,315 18,515,315
2020-12-21 13D/A SVA / Sinovac Biotech, Ltd. 18,515,315 18,515,315
2020-12-21 13D/A SVA / Sinovac Biotech, Ltd. 9,353,092 18,515,315
2020-02-14 13G/A VSTM / Verastem, Inc. 4,203,044 2,978,355
2020-02-14 13G/A YMTX / Yumanity Therapeutics Inc 4,178,778 4,545,308
2019-03-19 13D/A SVA / Sinovac Biotech, Ltd. 9,353,092 9,353,092
2019-03-18 13G/A VSTM / Verastem, Inc. 4,203,044 4,203,044
2019-03-18 13G/A YMTX / Yumanity Therapeutics Inc 4,178,778 4,178,778
2019-03-18 13G/A CJJD / China Jo-Jo Drugstores, Inc. 0 0
2019-03-18 13G/A LUMO / Lumos Pharma, Inc. 0 0
2019-03-18 13G/A AEZS / COSCIENS Biopharma Inc. 0 0
2019-03-18 13G/A ARQL / ArQule, Inc. 426,501 426,501
2019-03-18 13G/A EXEL / Exelixis, Inc. 5,679,761 5,679,761
2019-03-16 13G/A ARQL / ArQule, Inc. 3,956,171 426,501
2019-03-16 13G/A EXEL / Exelixis, Inc. 5,437,285 5,679,761
2019-03-16 13G/A AEZS / COSCIENS Biopharma Inc. 0
2019-03-16 13G/A CJJD / China Jo-Jo Drugstores, Inc. 1,261,131 0
2019-03-16 13G/A LUMO / Lumos Pharma, Inc. 2,589,503 0
2019-03-16 13G/A VSTM / Verastem, Inc. 1,769,581 4,203,044
2019-03-16 13G/A YMTX / Yumanity Therapeutics Inc 2,291,708 4,178,778
2018-06-15 13G YMTX / Yumanity Therapeutics Inc 2,291,708
2018-05-10 13G LUMO / Lumos Pharma, Inc. 2,589,503
2018-03-26 13D/A SVA / Sinovac Biotech, Ltd. 9,353,092 9,353,092
2018-03-23 13D/A SVA / Sinovac Biotech, Ltd. 9,353,092 9,353,092
2017-07-07 13D SVA / Sinovac Biotech, Ltd. 9,353,092 9,353,092
2017-06-13 13G VSTM / Verastem, Inc. 1,769,581
2017-06-13 13G MLNT / Melinta Therapeutics, Inc. 3,082,019
2017-02-15 13G CJJD / China Jo-Jo Drugstores, Inc. 1,261,131
2017-02-15 13G/A ARQL / ArQule, Inc. 3,956,171
2017-02-15 13G/A EXEL / Exelixis, Inc. 13,861,069 5,437,285
2016-04-28 13G EXEL / Exelixis, Inc. 13,861,069
2016-04-05 13G/A SVA / Sinovac Biotech, Ltd. 9,353,092
2013-06-17 13G ARQL / ArQule, Inc. 4,008,664
2013-05-09 13G SVA / Sinovac Biotech, Ltd. 3,385,776
2012-11-19 13G AEZS / COSCIENS Biopharma Inc. 1,796,433